Trends in postgraduate year 2 pharmacy residencies.

PURPOSE: The purpose of this study was to quantify the growth and trends in postgraduate year 2 (PGY2) pharmacy residencies. METHODS: Summaries of the American Society of Health-System Pharmacists (ASHP) Resident Matching Program from 2008 to 2021 were obtained. Only standalone PGY2 residencies were included in the analysis. Descriptive analyses were completed for data related to the programs and positions. RESULTS: From 2008 to 2021, the total number of ASHP-accredited PGY2 programs increased from 282 to 1,131 (301%) and the overall number of unfilled positions decreased from 22% (77 of 351) to 2% (34 of 1,492). The percentage of positions filled early increased from 23% (81 of 351) to 40% (594 of 1,492) during this time. In 2021, programs with a clinical focus accounted for 91.6% of total positions. The Ambulatory Care category accounted for the largest percentage of all PGY2 residency positions, at 19.2% (287 of 1,492) in 2021 compared to 12.8% (45 of 351) in 2008. The total share of PGY2 residency positions in the Critical Care category decreased from 22.8% (80 of 351) in 2008 to 13.7% (205 of 1,492) in 2021; however, the share of PGY2 residency positions in the Emergency Medicine category increased from 1.4% (5 of 351) to 5.9% (88 of 1,492). CONCLUSION: From 2008 to 2021 the total number of PGY2 residencies increased; however, this growth was uneven, as the share of positions within individual residency categories changed. It is important for pharmacy stakeholders to review the current state of postgraduate training and ensure it reflects the goals for future practice.

Evaluation of pharmacists' awareness of illegal online pharmacies and perceived impact on safe access to medicines.

Background: An estimated 95% of all online pharmacies operate unlawfully. Illegal online pharmacies distribute substandard and falsified medical products that may result in patient harm and suboptimal treatment, leading to an overall mistrust of medications, healthcare providers, and health systems. As medication experts, pharmacists are trusted to guide patients in selection of safe and effective medication therapy. Objective: The objective of this study was to determine gaps in knowledge and recognition of the negative clinical and safety impacts associated with illegal Internet pharmacies by licensed pharmacists. Methods: A 37-question electronic survey was developed and distributed to pharmacists across the United States by email via a database from the American Pharmacists Association. Descriptive statistics was utilized to analyze data. Results: A total of 347 pharmacists from across the United States responded to at least one question in the survey. In all, 58% of pharmacists reported a lack of confidence in their ability to counsel patients on the identification of illegal pharmacy websites. Fewer than 60% of pharmacists were able to accurately identify the legitimacy of a webpage based on visual characteristics. In addition, 75% of pharmacists reported being unfamiliar with resources available to help consumers identify safe and legitimate online pharmacies. Conclusion: Integration of the topic into pharmacy education curricula, training on available resources, and additional research into the prevalence and impact of illegal pharmacy websites are necessary to ensure that pharmacists and other healthcare professionals are adequately prepared to protect their communities from the threat of illegal online pharmacies.